AI assistant
PROCEPT BioRobotics Corp — Director's Dealing 2025
Jun 6, 2025
31665_dirs_2025-06-06_e7623ff6-0da1-4267-8cf6-1702a72e3689.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2025-06-06
Reporting Person: Shiblaq Hisham (EVP, Chief Comm. Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-06 | Common Stock | M | 20000 | $5.18 | Acquired | 83133 | Direct |
| 2025-06-06 | Common Stock | S | 12296 | $63.7115 | Disposed | 70837 | Direct |
| 2025-06-06 | Common Stock | S | 5904 | $64.6358 | Disposed | 64933 | Direct |
| 2025-06-06 | Common Stock | S | 1800 | $65.3506 | Disposed | 63133 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-06 | Stock Option (Right to Buy) | $5.18 | M | 20000 | Disposed | 2030-12-15 | Common Stock (20000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.24 to $64.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.24 to $65.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.29 to $65.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F4: The stock option is fully vested and exercisable.